QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

First published online 15 January 2008
doi: 10.1242/jcs.017145

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: jcs.017145v1 121/3/358    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fang, W. B. Articles by Chen, J. Search for Related Content PubMed PubMed Citation Articles by Fang, W. B. Articles by Chen, J. Social Bookmarking                         What's this?

Overexpression of EPHA2 receptor destabilizes adherens junctions via a RhoA-dependent mechanism

¹ Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA
² Department of Medicine, Division of Nephrology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA
³ Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA
⁴ Division of Rheumatology and Immunology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA
⁵ Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA

^* Author for correspondence (e-mail: jin.chen{at}vanderbilt.edu)

Accepted 4 November 2007

EPHA2 receptor tyrosine kinase is overexpressed in several human cancer types and promotes malignancy. However, the mechanisms by which EPHA2 promotes tumor progression are not completely understood. Here we report that overexpression of a wild-type EPHA2, but not a signaling-defective cytoplasmic truncation mutant (C), in human mammary epithelial cells weakens E-cadherin-mediated cell-cell adhesion. Interestingly, the total level of cadherins and the composition of the adherens junction complexes were not affected, nor was the tyrosine phosphorylation of the cadherin complex components changed. By contrast, RhoA GTPase activity was significantly affected by modulating the EPHA2 activity in MCF-10A cells. Treatment with a ROCK kinase inhibitor rescued cell-cell adhesion defects in EPHA2-overexpressing cells, whereas expression of constitutively activated Rho disrupted adherens junctions in C-expressing cells. EPHA2-dependent Rho activation and destabilization of adherens junctions appeared to be regulated via a signaling pathway involving Src kinase, low molecular weight phosphotyrosine phosphatase (LMW-PTP) and p190 RhoGAP. EPHA2 interacted with both Src and LMW-PTP, and the interactions increased in EPHA2-overexpressing cells. In addition, LMW-PTP phosphatase activity was elevated, and this elevation was accompanied by a decrease in tyrosine phosphorylation of p190 RhoGAP and destabilization of cell-cell adhesion. Expression of either a dominant negative LMW-PTP mutant, C12S, or a wild-type p190 RhoGAP rescued adhesion defects in EPHA2-overexpressing cells. Together, these data suggest that EPHA2 promotes tumor malignancy through a mechanism involving RhoA-dependent destabilization of adherens junctions.

Key words: EPHA2, RhoA, Adherens junction

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. A. Cercone, W. Schroeder, S. Schomberg, and T. C. Carpenter EphA2 receptor mediates increased vascular permeability in lung injury due to viral infection and hypoxia Am J Physiol Lung Cell Mol Physiol, November 1, 2009; 297(5): L856 - L863. [Abstract] [Full Text] [PDF]

				B. Annamalai, X. Liu, U. Gopal, and J. S. Isaacs Hsp90 Is an Essential Regulator of EphA2 Receptor Stability and Signaling: Implications for Cancer Cell Migration and Metastasis Mol. Cancer Res., July 1, 2009; 7(7): 1021 - 1032. [Abstract] [Full Text] [PDF]

				C. Leroy, C. Fialin, A. Sirvent, V. Simon, S. Urbach, J. Poncet, B. Robert, P. Jouin, and S. Roche Quantitative Phosphoproteomics Reveals a Cluster of Tyrosine Kinases That Mediates Src Invasive Activity in Advanced Colon Carcinoma Cells Cancer Res., March 15, 2009; 69(6): 2279 - 2286. [Abstract] [Full Text] [PDF]

				X. Huang, D. Wu, H. Jin, D. Stupack, and J. Y.J. Wang Induction of cell retraction by the combined actions of Abl-CrkII and Rho-ROCK1 signaling J. Cell Biol., November 17, 2008; 183(4): 711 - 723. [Abstract] [Full Text] [PDF]

				J. Larson, S. Schomberg, W. Schroeder, and T. C. Carpenter Endothelial EphA receptor stimulation increases lung vascular permeability Am J Physiol Lung Cell Mol Physiol, September 1, 2008; 295(3): L431 - L439. [Abstract] [Full Text] [PDF]

				W. B. Fang, D. M. Brantley-Sieders, Y. Hwang, A.-J. L. Ham, and J. Chen Identification and Functional Analysis of Phosphorylated Tyrosine Residues within EphA2 Receptor Tyrosine Kinase J. Biol. Chem., June 6, 2008; 283(23): 16017 - 16026. [Abstract] [Full Text] [PDF]

				W. B. Fang, R. C. Ireton, G. Zhuang, T. Takahashi, A. Reynolds, and J. Chen Overexpression of EPHA2 receptor destabilizes adherens junctions via a RhoA-dependent mechanism Development, February 15, 2008; 135(4): e1 - e1. [Full Text]